Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial. (Q52927812)
Jump to navigation
Jump to search
scientific article published in February 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial. |
scientific article published in February 2001 |
Statements
Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial. (English)
1 reference
J A Tavel
1 reference
L Fosdick
1 reference
ESPRIT Vanguard Group. ESPRIT Executive Committee
1 reference
1 February 2001
1 reference
22
1 reference
1
1 reference
42-48
1 reference